Venezuela could lose the bulk of its oil export revenues this year if the U.S. blockade stays in place, according to internal ...

The Evotrex-PG5 combines genuinely innovative features with a lower price point than competitors, but it's still a luxury buy ...

Brenden Borrowman, a retired Army veteran, founded Neurova Labs to focus on treating the physiological injury underlying ...

Two recipients of the Deferred Action for Childhood Arrivals (DACA) program in the Borderland have been in the national spotlight as the Trump administration expands its immigration crackdown.

Cytokinetics, Incorporated's (CYTK) shares surged 40.4% on Sept. 2, driven by positive results from a phase III study on cardiovascular candidate aficamten. On Aug. 30, Cytokinetics presented primary ...

During a medical event on Saturday, Cytokinetics (NASDAQ:CYTK) announced primary results from its Phase 3 MAPLE-HCM trial for lead asset aficamten in symptomatic obstructive hypertrophic ...

(RTTNews) - Cytokinetics, Incorporated (CYTK), Tuesday announced positive topline results from Phase 3 MAPLE-HCM study of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy ...

The U.S. Food and Drug Administration (FDA) on Thursday extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application (NDA) for Cytokinetics Inc's (NASDAQ:CYTK) ...

Bristol Myers Squibb & Co (NYSE:BMY) on Monday announced topline data from the Phase 3 ODYSSEY-HCM trial of Camzyos (mavacamten) for symptomatic New York Heart Association (NYHA) class II-III ...